GlassScriptPhysician profile
Mona Hanna
NPI 1740208594
$1,100.33
in general payments reported to CMS, 2019-2025
12 companies · $295 in 2025
The $295 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.42 · 2020: $36.83 · 2021: $51.22 · 2022: $95.97 · 2023: $267 · 2024: $272 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $315.69 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Cranial Technologies, INC | $167.57 | 2019-2025 | Doc Band |
| Corium, LLC | $106.32 | 2022-2023 | Azstarys |
| Glaxosmithkline, LLC. | $95.21 | 2019-2025 | Bexsero, Penmenvy, Pediarix |
| Alk-Abello, INC | $81.15 | 2024-2025 | Neffy, Odactra, Ragwitek |
| Seqirus USA INC | $80.48 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Pfizer INC. | $66.04 | 2019-2025 | |
| Sanofi Pasteur INC. | $58.90 | 2021-2023 | |
| Phadia US INC. | $51.50 | 2022-2025 | Immunocap |
| Sobi, INC | $40.40 | 2021-2023 | |
| Cepheid | $24.07 | 2025 | Genexpert |
| Acadia Pharmaceuticals INC | $13.00 | 2023 | Daybue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Hanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.